Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ghobrial

Showing results (371-380 of 532) with videos related to

Pageof 54
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 3, 2002
Donor and recipient outcomes in right lobe adult living donor liver transplantationRafik M Ghobrial, Sammy Saab, Charles Lassman, et al.
Blood|January 5, 2013
Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemiaIrene M Ghobrial, Federico Campigotto, Timothy J Murphy, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 4, 2008
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort StudyC E Freise, B W Gillespie, A J Koffron, et al.
British Journal of Haematology|April 3, 2015
Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantationMathew Weinstock, Yosra Aljawai, Elizabeth A Morgan, et al.
Leukemia Research|October 6, 2020
Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemiaJoan How, Orly Leiva, Thomas Bogue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Myeloma Cell Dynamics in Response to Treatment Supports a Model of Hierarchical Differentiation and Clonal EvolutionMin Tang, Rui Zhao, Helgi van de Velde, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Novel M-component based biomarkers in Waldenström's macroglobulinemiaXavier Leleu, Efstathios Koulieris, Dimitrios Maltezas, et al.
Bone Marrow Transplantation|September 4, 2003
Effect of thalidomide on stem cell collection and engraftment in patients with multiple myelomaI M Ghobrial, A Dispenzieri, K L Bundy, et al.
Blood|May 19, 2007
Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesisYu-Tzu Tai, Mariateresa Fulciniti, Teru Hideshima, et al.
European Journal of Haematology|February 4, 2012
The potential benefits of participating in early-phase clinical trials in multiple myeloma: long-term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomibPaul G Richardson, Jacob P Laubach, Robert L Schlossman, et al.
Pageof 54

Showing results (371-380 of 532) with videos related to

Sort By:
Pageof 54
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 3, 2002
Donor and recipient outcomes in right lobe adult living donor liver transplantationRafik M Ghobrial, Sammy Saab, Charles Lassman, et al.
Blood|January 5, 2013
Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemiaIrene M Ghobrial, Federico Campigotto, Timothy J Murphy, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 4, 2008
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort StudyC E Freise, B W Gillespie, A J Koffron, et al.
British Journal of Haematology|April 3, 2015
Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantationMathew Weinstock, Yosra Aljawai, Elizabeth A Morgan, et al.
Leukemia Research|October 6, 2020
Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemiaJoan How, Orly Leiva, Thomas Bogue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Myeloma Cell Dynamics in Response to Treatment Supports a Model of Hierarchical Differentiation and Clonal EvolutionMin Tang, Rui Zhao, Helgi van de Velde, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Novel M-component based biomarkers in Waldenström's macroglobulinemiaXavier Leleu, Efstathios Koulieris, Dimitrios Maltezas, et al.
Bone Marrow Transplantation|September 4, 2003
Effect of thalidomide on stem cell collection and engraftment in patients with multiple myelomaI M Ghobrial, A Dispenzieri, K L Bundy, et al.
Blood|May 19, 2007
Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesisYu-Tzu Tai, Mariateresa Fulciniti, Teru Hideshima, et al.
European Journal of Haematology|February 4, 2012
The potential benefits of participating in early-phase clinical trials in multiple myeloma: long-term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomibPaul G Richardson, Jacob P Laubach, Robert L Schlossman, et al.
Pageof 54